Delivery Order SPE2DB24D8001-SPE2DB24FKZCS
Award Date
9/26/24
Potential Completion Date
9/27/24
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical division. The $1,443.39 firm fixed-price contract is for the delivery of ENTRESTO 49 MG-51 MG TABLET 60S, a pharmaceutical product. This award is part of Dakota Drug's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA under the ECAT Generation V Program, which allows the company to provide a wide range of...
This federal contract award, valued at $6,292.31, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a delivery order for the pharmaceutical product ENTRESTO 97 MG-103 MG TABLET 60S, with a period of performance through May 21, 2024. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop Support Medical's ECAT...
This federal contract award, valued at $6,782.38, was made by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of ENTRESTO 49 MG-51 MG TABLET 60S, a pharmaceutical product, to support U.S. Armed Forces medical operations. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC), identified as SPE2DB24D8001, which has a ceiling value of $999,999,999.00. This IDC is part of the DLA...
This federal contract award, valued at $15,447.18, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC is part of the DLA Troop Support Medical's ECAT Generation V Program and covers the delivery of a wide range of pharmaceutical products,...
This federal contract award, identified as SPE2DX15D8001|SPE2DX24FBQBV, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $2,117.23 Firm Fixed Price delivery order is for the pharmaceutical product ENTRESTO 24 MG-26 MG TABLET 60S. The award is not associated with a set-aside program and has an ultimate completion date of November 29, 2023. Dakota Drug, Inc. is a key supplier to the DLA, holding a $999,999,999.00 Indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a $2,206.74 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of 60 tablets of the prescription medication Entresto (24 mg-26 mg) to support U.S. Armed Forces medical operations. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. under the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,052.23, is for the delivery of ENTRESTO 49 MG-51 MG tablets to support U.S. Armed Forces medical operations. The award is part of the DLA Troop Support Medical's ECAT Generation V Program, a larger indefinite delivery contract (IDC) with a ceiling value of $999,999,999.00 that allows Dakota Drug, Inc. to provide...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of ENTRESTO 24 MG-26 MG TABLET 60S pharmaceutical products. The contract has a firm fixed-price, with a ceiling value of $8,811.79 and a period of performance through February 24, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of ENTRESTO 24 MG-26 MG TABLET 60S, a pharmaceutical product. The contract has a ceiling value of $10,729.29 and an ultimate completion date of May 23, 2024. Dakota Drug, Inc. is an established federal contractor, holding a significant single-award Indefinite Delivery Contract (IDC) with the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,150.37, is for the delivery of ENTRESTO 97 MG-103 MG tablets. It is part of the DLA Troop Support Medical's ECAT Generation V Program, an Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00 and a performance period through December 31, 2025. This unrestricted, non-set-aside...